Nanomedicine-Based Strategies for Regulating Abnormal Amino Acid Metabolism in Liver Diseases
Sustainable Engineering Novit · 2026
DOI: 10.53941/sen.2026.100001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sustainable Engineering Novit, 2026. Verfasst von Lin Yu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Distinguished Professorship Program of Jiangsu Province, Natural Science Foundation of the Jiangsu Higher Education Insti.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) has been proposed as a more precise term to characterize steatosis amid metabolic dysregulation and is projected to emerge as the predominant cause of hepatocellular carcinoma (HCC) globally, given the rising prevalence of metabolic comorbidities. Particularly in its inflammatory form, known as metabolic dysfunction-associated steatohepatitis (MASH), hepatic metabolism is profoundly altered. Amino acids are fundamental building blocks that support cellular metabolism and biosynthesis, alongside monosaccharides and fatty acids. Emerging research suggests that aberrant amino acid metabolism in MASLD/MASH and HCC impacts mitochondrial function and redox equilibrium. Nonetheless, the involvement of amino acid metabolism in the progression from MASLD/MASH to HCC is still inadequately comprehended. This review summarizes the aberrant amino acid metabolism in MASLD/MASH and HCC, as well as nanomedicine-based approaches for modulating this metabolism to facilitate the discovery of more effective biomarkers and precision therapeutics for the prevention of MASLD/MASH and HCC.
Förderung
- National Natural Science Foundation of China
- Distinguished Professorship Program of Jiangsu Province
- Natural Science Foundation of the Jiangsu Higher Education Insti
Zitieren
APA
Yu, L., Zhang, L., Sun, X., Liu, J., & Wu, M. (2026). Nanomedicine-Based Strategies for Regulating Abnormal Amino Acid Metabolism in Liver Diseases. Sustainable Engineering Novit. https://doi.org/10.53941/sen.2026.100001
Vancouver
Yu L, Zhang L, Sun X, Liu J, Wu M. Nanomedicine-Based Strategies for Regulating Abnormal Amino Acid Metabolism in Liver Diseases. Sustainable Engineering Novit. 2026. doi:10.53941/sen.2026.100001
BibTeX
@article{Yu2026,
author = {Yu, Lin and Zhang, Lu and Sun, Xiaoqi and Liu, Jingjing and Wu, Min},
title = {Nanomedicine-Based Strategies for Regulating Abnormal Amino Acid Metabolism in Liver Diseases},
journal = {Sustainable Engineering Novit},
year = {2026},
doi = {10.53941/sen.2026.100001}
}
EUVIMED